Health in Zimbabwe 1,219 indicators covering health for Zimbabwe. IndicatorLatest Year10-yr change Rank Cholera case fatality rate 4.92 2019 up 256.5% 8th Medical doctors not further defined 2 2023 down 99.8% 149th Life satisfaction vs life expectancy 62.77 2023 up 10.4% 219th Estimate of current cigarette smoking prevalence 5.9% 2030 down 22.4% 130th Estimate of current cigarette smoking prevalence (%) 7.1% 2030 down 22.8% 120th Tb patients tested positive for hiv 8,056 2021 down 70.8% 11th Number of children aged 6-59 months with anaemia 808.13 2019 down 17.9% 54th Prevalence of anaemia in children aged 6-59 months 37.8% 2019 down 25.6% 67th Number of deaths attributed to non-communicable diseases, by type of 10,876 2019 up 16.6% 78th Hepatitis B surface antigen (HBsAg) prevalence 1.8% 2024 down 10.0% 13th Mean hemoglobin level of children aged 6-59 months 113 2019 up 3.7% 126th Estimated number of MDR/RR-TB incident cases 660 2024 down 70.0% 48th Mortality caused by road traffic injury 41.2 per 100,000 population 2019 up 8.7% 2nd Mortality caused by road traffic injury, female 16.9 per 100,000 female population 2019 up 12.7% 22nd Mortality caused by road traffic injury, male 67.9 per 100,000 male population 2019 up 7.4% 2nd Countries with birth registration data that are at least 90 percent 0 2024 — 148th Ipv vaccine coverage 88 2024 up 35.4% 123rd Tb patients living with hiv receiving art 7,647 2021 down 53.9% 11th HIV-positive TB patients on ART (antiretroviral therapy) 96.0% 2024 up 11.6% 74th Hospital beds 19.47 2014 up 7.3% 93rd Treatment success rate for patients treated for MDR-TB 69.0% 2022 down 8.0% 101st New leprosy case detection rate per 1 000 000 population 0.601 2024 — 97th Treatment success rate: HIV-positive TB cases 88 2023 up 29.4% 28th Prevalence of wasting, weight for height 5.1% 2024 up 59.4% 40th Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) 86.0% 2025 — 96th International Health Regulations core capacity scores, SPAR version 20 2025 — 162nd Prevalence of underweight, weight for age 9.6% 2024 down 14.3% 51st Leprosy registered prevalence rate per 1 000 000 population 0.361 2024 up 5.6% 103rd Leprosy - Number of new leprosy cases among children 0 2024 — 69th Leprosy - Number of cases registered for treatment 6 2024 down 66.7% 89th New leprosy child case detection rate (less than 15 years of age) per 0 2024 — 69th Children (0-14) living with HIV 64,000 2024 down 54.3% 6th Ipv1 number unvaccinated 47,142 2023 — 56th Children living with hiv 64,000 2024 down 54.3% 6th Contraceptive prevalence, any method 66.8% 2015 up 11.0% 29th Children (ages 0-14) newly infected with HIV 2,800 2024 down 68.5% 9th Number of reported cases of poliomyelitis by wild poliovirus 0 2023 — 3rd Age-standardized prevalence of current tobacco use among persons aged 11.0% 2024 down 20.9% 129th Number of children newly infected with hiv 2,800 2024 down 68.5% 9th Share of children under fifteen years old with hiv 2,843 2024 down 68.2% 9th Number of female leprosy new cases 6 2024 down 33.3% 69th Estimated number of malaria deaths 381 2024 down 86.4% 44th Estimated number of malaria cases 148,833 2024 down 86.4% 48th National smoking ban: NUMBER OF PLACES SMOKE-FREE 4 2022 unchanged 114th Contraceptive prevalence, any modern method 65.8% 2015 up 12.7% 19th Number of prevalent tuberculosis cases 44,000 2014 down 29.0% 38th Estimated malaria incidence 11.36 2024 down 88.4% 50th Estimated malaria mortality rate 2.91 2024 down 88.4% 44th Number of new G2D leprosy cases 10 2024 down 44.4% 52nd Leprosy - New leprosy cases with G2D rate per 1 000 000 population 0.601 2024 down 44.8% 56th Taxes as a % of price: total tax 34.5% 2022 up 4.4% 146th Taxes as a % of price: value added tax 13.0% 2022 unchanged 84th Taxes as a % of price: ad valorem excise 13.1% 2022 — 74th Taxes as a % of price: specific excise 8.4% 2022 down 58.2% 126th Taxes as a % of price: import duties 0.0% 2022 — 38th Taxes as a % of price: other taxes 0.0% 2022 — 57th Vitamin A supplementation coverage rate 37.0% 2023 up 8.8% 38th Estimated number of children needing antiretroviral therapy based on 61,000 2025 down 59.3% 8th Prevalence of severe wasting, weight for height 1.6% 2024 up 128.6% 22nd Physical activity policies for activie societies 20 2023 up 100.0% 2nd ← Previous Page 15 of 21 Next →